VACINAL COMPOSITION FOR PROTECTION AGAINST TEGUMENTARY LEISHMANIASIS

摘要

vaccine composition for protection against cutaneous leishmaniasis. The present technology deals with vaccine compositions comprising at least one of the nine peptides defined by sequence 1 to 9 capable of stimulating the development of a high interferon-gamma (ifn) t-helper 1 (th1) cellular immune response. -¿) and low levels of interleukin-4 (il-4) to prevent cutaneous leishmaniasis in mammals.